Market Closed -
OTC Markets
11:25:25 2024-07-15 am EDT
|
5-day change
|
1st Jan Change
|
0.401
USD
|
+33.67%
|
|
-24.81%
|
-33.17%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2.619
|
7.373
|
7.17
|
4.345
|
Enterprise Value (EV)
1 |
2.618
|
7.882
|
8.177
|
5.507
|
P/E ratio
|
-1.69
x
|
-1.85
x
|
-3
x
|
-4.29
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
13,403,204
x
|
41,642,551
x
|
-83,314,018
x
|
FCF Yield
|
-
|
0%
|
0%
|
-0%
|
Price to Book
|
-6.2
x
|
-2.64
x
|
-1.47
x
|
-0.74
x
|
Nbr of stocks (in thousands)
|
806
|
7,228
|
7,242
|
7,242
|
Reference price
2 |
3.250
|
1.020
|
0.9900
|
0.6000
|
Announcement Date
|
3/2/21
|
1/26/22
|
3/2/23
|
4/15/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-1.433
|
-3.501
|
-2.628
|
-1.4
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-1.441
|
-3.682
|
-2.378
|
-1.006
|
Net income
1 |
-1.444
|
-3.684
|
-2.381
|
-1.008
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-1.920
|
-0.5500
|
-0.3300
|
-0.1400
|
Free Cash Flow
|
-
|
0.588
|
0.1964
|
-0.0661
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/2/21
|
1/26/22
|
3/2/23
|
4/15/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
0.51
|
1.01
|
1.16
|
Net Cash position
1 |
0
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0.59
|
0.2
|
-0.07
|
ROE (net income / shareholders' equity)
|
-
|
229%
|
62%
|
18.7%
|
ROA (Net income/ Total Assets)
|
-
|
-602%
|
-619%
|
-397%
|
Assets
1 |
-
|
0.6123
|
0.3848
|
0.254
|
Book Value Per Share
2 |
-0.5200
|
-0.3900
|
-0.6700
|
-0.8100
|
Cash Flow per Share
2 |
0.4400
|
0.0300
|
0.0300
|
0.0200
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/2/21
|
1/26/22
|
3/2/23
|
4/15/24
|
|
1st Jan change
|
Capi.
|
---|
| -33.17% | 2.9M | | +22.15% | 46.56B | | +45.94% | 41.67B | | -2.37% | 41.16B | | +33.84% | 32.4B | | -6.35% | 28.1B | | +20.42% | 28.18B | | +48.83% | 14.52B | | +45.00% | 13.74B | | +0.06% | 12.17B |
Other Biotechnology & Medical Research
|